SCHEMBL6522968

SCHEMBL6522968

O=c1[nH]c2ncccc2c2cc(Nc3ccc(F)cc3)ccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 12/20 0.59
PARP1 P09874 2/20 0.59
MAPT P10636 3/20 0.49
KDM4E B2RXH2 1/20 0.49
MEN1 O00255 1/20 0.49
APAF1 O14727 1/20 0.49
TDP2 O95551 1/20 0.49
ALDH1A1 P00352 1/20 0.49
GAA P10253 1/20 0.49
THRB P10828 1/20 0.49
HPGD P15428 1/20 0.49
CDC25B P30305 1/20 0.49
CASP3 P42574 1/20 0.49
RECQL P46063 1/20 0.49
BLM P54132 1/20 0.49
CASP7 P55210 1/20 0.49
CASP9 P55211 1/20 0.49
CASP6 P55212 1/20 0.49
KMT2A Q03164 1/20 0.49
CASP8 Q14790 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6525364 0.90 AURKA (0.56) AURKAPARP1MAPTKDM4EAURKB
SCHEMBL6517435 0.89 AURKA (0.67) AURKAPARP1MAPTKDM4EAPAF1
SCHEMBL3453800 0.87 AURKA (0.68) AURKAPARP1MAPTAURKBMAPK14
SCHEMBL6520467 0.86 AURKA (0.59) AURKAPARP1MAPTMEN1ALDH1A1
SCHEMBL12787031 0.85 AURKA (0.54) AURKAPARP1MAPTMEN1KMT2A
SCHEMBL6520992 0.84 AURKA (0.59) AURKAPARP1MAPTKDM4EKMT2A
SCHEMBL6521930 0.84 PARP1 (0.52) AURKAPARP1MAPTKDM4EALDH1A1
SCHEMBL6526939 0.83 AURKA (0.67) AURKAPARP1MAPTKDM4EAPAF1
SCHEMBL3454414 0.83 AURKA (0.55) AURKAPARP1AURKB
SCHEMBL6523556 0.83 AURKA (0.58) AURKAPARP1CDC25BAURKBRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735584-B2 Protein kinase inhibitors and use thereof MERCK PATENT GMBH (DE) 2014-05-27 US disclosed
US-8735584-B2 Protein kinase inhibitors and use thereof MERCK PATENT GMBH (DE) 2014-05-27 US disclosed
US-8735584-B2 Protein kinase inhibitors and use thereof MERCK PATENT GMBH (DE) 2014-05-27 US disclosed
EP-2254889-B1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2012-12-19 EP disclosed
EP-2254889-B1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2012-12-19 EP disclosed
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-03-03 US disclosed
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-03-03 US disclosed
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-03-03 US disclosed
WO-2009108670-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK SERONO S.A. (CH) 2009-09-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MAP4K2, MAP3K20, MAP4K1 AURKA 538/4885PARP1 1693/4885MAPT 1565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.